ZOLL Medical Corporation (NASDAQ: ZOLL) shares soared
in trading today after the Chelmsford, Massachusetts-based company announced
that the Centers for Medicare and Medicaid Services (CMS) reaffirmed coverage
for its LifeVest Wearable Defibrillator.
ZOLL Medical shares rose to an intra-day high of
$63.86 in trading today, and at last check, the stock was up more than 28% on
above average volume. The rally has pushed ZOLL Medical shares above their
50-day and 200-day moving average.
To get more information on ZOLL Medical Corporation
please click here…